MAD Refractory: Solid Tumor QD w/o Break
Clinical trial NCT00207012 · COMPLETED
Trial details
- NCT number
- NCT00207012
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-02-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.